included other income) increased substantially by 16% yoy. EBITDA margin rose from 25% of hospital revenue in 4Q18 to 26% in 4Q19. This was mainly attributable to the increase of non-SW revenue. Financing
this quarter, the ratios were not substantially changed yoy. Trade receivable and Trade payable period were decreased while inventory period was slightly increased. For the financial risk perspective
revenues, which substantially pushed up its net profit and net profit margin. บริษัท ดโีอด ีไบโอเทค จ ำกดั (มหำชน) 111 หมู่ที่ 2 ต ำบลท่ำจีน อ ำเภอเมืองสมุทรสำคร จังหวดัสมุทรสำคร 74000 111 Moo 2 Tambon
substantially pushed up its net profit and net profit margin. Financial position The Company recorded total assets of Baht 1,424.80 million as at June 30, 2018, a Baht 970.60 million or 213.69% growth from that
million Baht decreased by 3.1 percent compared to the same period of the previous year. Thanks to such positive signs in the second quarter, and revenues from sales in several countries grew substantially
days to less than 10 days more recently. Lower inventory levels of PTA, higher demand growth and lesser capacity addition cre- ate a positive outlook for the Asian PTA industry. IVL has seen the
was seen improving. Moving Annual Total (MAT) March 2018 of domestic RTD fruit juice market was Baht 12,542 million, a decrease of 10% YoY. Meanwhile, the overall domestic beverage market slowed down by
revenue from real estate. However, gross margins for the year ended 31 December 2019 and 2018 were 42.32% and 42.62% respectively. It could be seen that gross margin percentage of the company does not
, compared to 307,760 units in Jan-Mar 2016. Decreases were seen in many markets, mainly in Asia, Middle East, Central and South America, and Africa. Profit & Loss Analysis (Unit: Million Baht unless otherwise